Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Leukemia through trial conditions or approval indications mapped to it or to one of its descendant entities.
26 drugs · 850 active trials
42 drugs · 1,288 active trials
Outside the funnel: Phase not stated 1 · Withdrawn 3. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 17 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Cabozantinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2013-11 |
| FLT3/ABL/Aurora Kinase Inhibitor KW-2449 | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2006-06 |
| Fluorouracil | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 1998-01 |
| Ibuprofen | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | Jul 28, 2020 |
| Loncastuximab Tesirine | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2016-03 |
| Prexasertib | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | May 4, 2016 |
| Vinorelbine | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2006-05 |
| 5-Fluoro-2-Deoxycytidine | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2009-12 |
| Abemaciclib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Abiraterone | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Adavosertib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Aug 18, 2015 |
| Afatinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Alpelisib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2012-03 |
| Alvespimycin | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2010-05 |
| Bicalutamide | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Bone Marrow Transplantation | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2011-08 |
| Cabazitaxel | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Capecitabine | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Cetuximab | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Nov 6, 2024 |
| Dabrafenib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Dactolisib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2012-06 |
| Darolutamide | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Enzalutamide | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Enzastaurin | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2007-05 |
| FLT3 Inhibitor FF-10101 Succinate | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | May 5, 2017 |
| FOLFIRI Regimen | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Sep 23, 2020 |
| HDAC Inhibitor REC-2282 | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | May 4, 2010 |
| HDM2 Inhibitor MK-8242 | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Nov 18, 2011 |
| Immunotherapy | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2007-03 |
| Lenvatinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Lorlatinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Mcl-1 Inhibitor MIK665 | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Jun 23, 2021 |
| Mitomycin | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 1996-09 |
| Nab-paclitaxel | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Niraparib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2008-09 |
| Nirogacestat | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Jun 25, 2009 |
| Pan-Mutant-IDH1 Inhibitor Bay-1436032 | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Jun 14, 2017 |
| Pemetrexed | Phase 1 | Early Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2007-01 |
| Pertuzumab | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Pralatrexate | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2010-03 |
| Quisinostat | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2008-12 |
| Raltitrexed | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 1998-09 |
| Rebastinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2009-03 |
| RG7112 | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Nov 28, 2012 |
| Salirasib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2006-05 |
| Sertraline | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Aug 11, 2016 |
| Tirbanibulin | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2013-12 |
| Trabectedin | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Jun 18, 2019 |
| Trastuzumab Emtansine | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 1, 2020 |
| Triciribine | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2006-08 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.